HIVE Blockchain gets price target cut at PI Financial, keeps “buy” rating

On the back of dropping cryptocurrency prices, HIVE Blockchain (TSXV:HIVE) just got a target price cut from PI Financial’s David Kwan, who in a corporate update to clients today reiterated his “Buy” rating with a new target of C$0.85 (was C$1.30).

Cryptocurrency miner HIVE Blockchain recently announced that its new ASIC-powered bitcoin facility will be opened in North America rather than the previously planned Sweden. HIVE says the move is due to cheaper power costs in N.A. and that the added 200 PH/s (petahash per second) hash rate will be made up in the meantime through a cloud hosting agreement, starting on September 30.

Kwan says he views the move as slightly positive.

“The expansion of its operations into North America further diversifies HIVE’s mining operations, with existing facilities in Iceland and Sweden along with the potential for expansion in Norway via the Kolos acquisition,” says Kwan. “Accordingly, HIVE will have a diverse base of operations in three (or four, if/when Norway gets off the ground) relatively politically stable jurisdictions.”

The analyst has lowered his revenue and EBITDA estimates to reflect the pullback in crypto prices, which he says could make mining activity unprofitable for an increasing number of operations and could lead to a slowdown or a decline in network hash rates and difficulty in cryptomining.

For FY19, Kwan expects HIVE will generate Adj. EBITDA of $12.2 million (was $20.9 million) on revenue of $44.2 million (was $53.0 million) and for FY20, he expects Adj. EBITDA of $14.9 million (was $20.0 million) on a topline of $54.8 million (was $60.6 million).

Kwan’s target is based on a 12x CY19 Adj. EBITDA estimate and represents a projected 12-month return of 19.7 per cent.

Tagged with: hive
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

CHAR Technologies wins price target raise from this analyst

On Oct. 22, Paradigm Capital analyst Marvin Wolff raised his target on CHAR Technologies (CHAR Technologies Stock Quote, Chart, News,… [Read More]

2 days ago

Can ATS stock bounce back?

Stifel analyst Justin Keywood maintained his “Buy” rating and $44.00 target on ATS Corporation (ATS Corporation  Stock Quote, Chart, News,… [Read More]

2 days ago

Three Canadian stocks analysts think could double

Markets have been choppy, but billionaire investor Bill Ackman sees the potential for a much stronger backdrop in 2027. Speaking… [Read More]

2 days ago

Atlas Engineered Products: Buy, Sell or Hold?

Beacon Securities analyst Russell Stanley reiterated his “Buy” rating and $1.00 target on Atlas Engineered Products (Atlas Engineered Products Stock… [Read More]

2 days ago

Atrium Therapeutics is a buy, this analyst says

Roth Capital Partners analyst Boobalan Pachaiyappan initiated coverage of Atrium Therapeutics (Atrium Therapeutics, Stock Quote, Chart, News, Analysts, Financials NASDAQ:RNA)… [Read More]

3 days ago

Texas Instruments is the anti-data center stock, this investor says

Goodreid Investment Counsel president and CEO Gordon Reid says Texas Instruments (Texas Instruments Stock Quote, Chart, News, Analysts, Financials NASDAQ:TXN)… [Read More]

3 days ago